The utility of the early intervention by the multi-disciplinary cooperation in the skin reaction due to EGFR inhibitor: Phase II study

ABSTRACT: Interventions: We conduct an introduction to the chemotherapy center from diagnosis and treatment department, and, in chemotherapy center, a medical oncologist, a pharmacist or a nurse conducts side effect monitoring using an episode of care sheet (the skin reaction monitoring sheet that we made for the purpose of doing multi-disciplinary cooperation smoothly) at chemotherapy enforcement. By severity of the skin reaction, a tumor physician refers you to a dermatologist, and side effect monitoring, a dermatologist intervene after the next treatment. Primary outcome(s): Severe skin reaction incidence Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer, Head And Neck Cancer

PROVIDER: 2643491 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR